These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Nilsson L, Astrand-Grundström I, Anderson K, Arvidsson I, Hokland P, Bryder D, Kjeldsen L, Johansson B, Hellström-Lindberg E, Hast R, Jacobsen SE. Blood; 2002 Jul 01; 100(1):259-67. PubMed ID: 12070035 [Abstract] [Full Text] [Related]
6. Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience. Alzahrani M, Power M, Abou Mourad Y, Barnett M, Broady R, Forrest D, Gerrie A, Hogge D, Nantel S, Sanford D, Song K, Sutherland H, Toze C, Nevill T, Narayanan S. Biol Blood Marrow Transplant; 2018 Jun 01; 24(6):1209-1215. PubMed ID: 29474870 [Abstract] [Full Text] [Related]
7. Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation. Tamari R, Oran B, Hilden P, Maloy M, Kongtim P, Papadopoulos EB, Rondon G, Jakubowski AA, Andersson BS, Devlin SM, Ahmed S, Popat UR, Ponce D, Chen J, Sauter C, Young JW, de Lima M, Perales MA, O'Reilly RJ, Giralt SA, Champlin RE, Castro-Malaspina H. Biol Blood Marrow Transplant; 2018 May 01; 24(5):1079-1087. PubMed ID: 29325829 [Abstract] [Full Text] [Related]
9. [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in the treatment of secondary acute myeloid leukemia]. Yuan XL, Wu YB, Song XL, Chen Y, Lu Y, Lai XY, Shi JM, Liu LZ, Zhao YM, Yu J, Yang LX, Lan JP, Cai Z, Huang H, Luo Y. Zhonghua Xue Ye Xue Za Zhi; 2024 Jan 14; 45(1):41-47. PubMed ID: 38527837 [Abstract] [Full Text] [Related]
14. Expressions of CD96 and CD123 in Bone Marrow Cells of Patients with Myelodysplastic Syndromes. Zhang W, Shao Z, Fu R, Wang H, Li L, Liu H. Clin Lab; 2015 Jan 14; 61(10):1429-34. PubMed ID: 26642704 [Abstract] [Full Text] [Related]
15. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8. Konuma T, Miyazaki Y, Uchida N, Ohashi K, Kondo T, Nakamae H, Takahashi S, Mori T, Ozawa Y, Kato C, Iwato K, Fukuda T, Ichinohe T, Atsuta Y, Ishiyama K, Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant; 2017 Jan 14; 23(1):75-80. PubMed ID: 27777139 [Abstract] [Full Text] [Related]
16. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia. Monreal MB, Pardo ML, Pavlovsky MA, Fernandez I, Corrado CS, Giere I, Sapia S, Pavlovsky S. Cytometry B Clin Cytom; 2006 Mar 14; 70(2):63-70. PubMed ID: 16470534 [Abstract] [Full Text] [Related]